These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1195 related items for PubMed ID: 17087942

  • 1. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR.
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [Abstract] [Full Text] [Related]

  • 2. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
    Ogino S, Kawasaki T, Kirkner GJ, Ohnishi M, Fuchs CS.
    BMC Cancer; 2007 May 02; 7():72. PubMed ID: 17474983
    [Abstract] [Full Text] [Related]

  • 3. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.
    Hum Pathol; 2007 Jun 02; 38(6):842-9. PubMed ID: 17350669
    [Abstract] [Full Text] [Related]

  • 4. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
    Dahlin AM, Palmqvist R, Henriksson ML, Jacobsson M, Eklöf V, Rutegård J, Oberg A, Van Guelpen BR.
    Clin Cancer Res; 2010 Mar 15; 16(6):1845-55. PubMed ID: 20197478
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between CpG island methylator phenotype and genetic instability in sporadic colorectal cancer].
    Cai GX, Xu Y, Cai SJ, Shi YQ, Lian P, Peng JJ, Guan ZQ, Du X.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov 15; 10(6):555-60. PubMed ID: 18000779
    [Abstract] [Full Text] [Related]

  • 6. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N.
    Mol Cancer Res; 2008 Apr 15; 6(4):585-91. PubMed ID: 18403637
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC, Choi JS, Roh SA, Cho DH, Kim TW, Kim YS.
    Ann Surg Oncol; 2010 Jul 15; 17(7):1767-76. PubMed ID: 20077021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH, Derks S, Draht MX, Smits KM, Melotte V, Van Neste L, Tournier B, Jooste V, Chapusot C, Weijenberg MP, Herman JG, de Bruïne AP, van Engeland M.
    Clin Cancer Res; 2014 Jun 15; 20(12):3261-71. PubMed ID: 24928946
    [Abstract] [Full Text] [Related]

  • 13. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.
    Matsuzaki K, Deng G, Tanaka H, Kakar S, Miura S, Kim YS.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8564-9. PubMed ID: 16361538
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS.
    J Pathol; 2006 Oct 15; 210(2):147-54. PubMed ID: 16850502
    [Abstract] [Full Text] [Related]

  • 15. Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones.
    Tanaka J, Watanabe T, Kanazawa T, Tada T, Kazama Y, Tanaka T, Nagawa H.
    J Surg Oncol; 2007 Dec 01; 96(7):611-8. PubMed ID: 17786961
    [Abstract] [Full Text] [Related]

  • 16. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases.
    Messick CA, Church JM, Liu X, Ting AH, Kalady MF.
    Ann Surg Oncol; 2010 Feb 01; 17(2):425-31. PubMed ID: 19885699
    [Abstract] [Full Text] [Related]

  • 17. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M, Sakakura C, Nagata T, Komiyama S, Miyashita A, Hamada T, Kuryu Y, Ikoma H, Kubota T, Kimura A, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Ida H, Ito K, Chiba T, Ito Y, Otsuji E.
    Anticancer Res; 2010 Jul 01; 30(7):2673-82. PubMed ID: 20682997
    [Abstract] [Full Text] [Related]

  • 18. BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients.
    Ang PW, Li WQ, Soong R, Iacopetta B.
    Cancer Lett; 2009 Jan 18; 273(2):221-4. PubMed ID: 18778891
    [Abstract] [Full Text] [Related]

  • 19. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH, Bae JM, Cho NY, Kang GH.
    Oncotarget; 2016 Mar 22; 7(12):14095-111. PubMed ID: 26883113
    [Abstract] [Full Text] [Related]

  • 20. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.
    Ogino S, Kawasaki T, Kirkner GJ, Suemoto Y, Meyerhardt JA, Fuchs CS.
    Gut; 2007 Nov 22; 56(11):1564-71. PubMed ID: 17339237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.